Metraipolis › archive › dc_164339149d52
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41304997
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304997
- DOI
- 10.3390/ph18111752
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T11:33:17.130Z
- SHA-256 of the archived text
2df967c543a4cd2759c49dddcb9e79dec74660a6d448fe88f0b188f7f93f3b8b- Stable URL of this page
https://metraipolis.com/documento/dc_164339149d52
How to cite
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41304997 — Europe PMC (en), https://europepmc.org/article/MED/41304997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_164339149d52 (Metraipolis archive dc_164339149d52, sha256 2df967c543a4cd2759c49dddcb9e79dec74660a6d448fe88f0b188f7f93f3b8b)
BibTeX
@misc{dc164339149d52,
title = {YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41304997},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304997},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_164339149d52; sha256 2df967c543a4cd2759c49dddcb9e79dec74660a6d448fe88f0b188f7f93f3b8b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304997. Agents can read the archived copy with the MCP tool read_document.